Lasting drug delivery.
Enduring vision.
A team committed to redefining ophthalmic treatment
Our story
SpyGlass Pharma™ was founded in 2019 by Malik Y. Kahook, MD and Glenn Sussman to redefine the treatment of chronic ophthalmic diseases through sustained drug delivery. With more than 15 years of partnership, Malik and Glenn have combined their complementary expertise—Dr. Kahook as a leading ophthalmic surgeon, innovator, and academic, and Mr. Sussman as a medical device engineer and product development leader. Their shared vision to modernize glaucoma surgery and improve patient outcomes has driven the creation and evolution of SpyGlass Pharma.
Originating from the Sue Anschutz-Rodgers Eye Center of the University of Colorado School of Medicine, the SpyGlass Drug Delivery Platform integrates known drugs, procedures, and devices to provide long-term disease control and vision preservation.
Led by CEO Patrick Mooney, SpyGlass is powered by a team with deep expertise across every stage of ophthalmic innovation—from discovery to late-stage development and commercialization. With decades of experience running large-scale clinical programs and launching category-defining therapies, our leadership combines scientific rigor with proven operational excellence.
Together, we’re advancing a new era of ophthalmic care built on proven science and enduring innovation.
Our mission
Significantly improve the lives of patients with chronic eye conditions.
Our vision
Transform chronic eye care with best-in-class sustained drug delivery, giving patients enduring vision.
Our guiding principles
- We create for patients
- We share responsibility for our common mission
- We thrive through continuous improvement
- We commit to a culture of transparent communication
- We recognize our differences as collective strength
- We grow with agility
Our culture
We create for patients.
The work we do is grounded in purpose and carried forward by people who thrive on solving tough problems. Our teams work with curiosity, accountability, and a shared focus on creating long-lasting benefits for patients. Collaboration is part of how we operate, and we take pride in combining rigorous science with a supportive environment where individuals can contribute and innovate together.
Our team
SpyGlass is home to industry professionals who know how to deliver meaningful change in eye care. Our scientists, engineers, and clinicians bring a wealth of experience in ophthalmology, drug delivery, and device innovation. They work with leaders who have taken therapies from early concept to clinical success and commercial launch. This is a team built to solve tough problems and bring forward therapies designed to protect vision for years to come.
SpyGlass leaders
Behind our accomplished scientists and engineers is a seasoned leadership team with ophthalmology, R&D,
communications, and operations expertise.
Patrick Mooney
Chief Executive Officer
Malik Y. Kahook, MD
Co-founder, President, Chief Medical Officer, and Executive Chair of the Board
Glenn Sussman
Co-founder and Chief Technology Advisor
James Dennewill
Chief Operating Officer
Jean-Frédéric Viret
Chief Financial Officer
Chetan Pujara, PhD
Chief Research and Development Officer
Paul Yoo
Senior Vice President, Clinical Development
Nina Nguyen
Senior Vice President, Regulatory & Quality
Long Doan
Vice President, Head of Clinical Operations
Anand Sundaram
Vice President, Head of Commercial
Brian Aukshunas, CPA
Vice President, Finance
Rachel Gilette
Vice President, Human Resources
Board of Directors
With expertise spanning academic medicine, medtech innovation, and capital markets, our board provides the strategic oversight that drives clinical rigor, operational excellence, and the advancement of sustained drug delivery.
Patrick Mooney
Chief Executive Officer
Malik Y. Kahook, MD
Co-founder, President, Chief Medical Officer, and Executive Chair of the Board
Ali Behbahani, MD
Board Director, New Enterprise Associates (NEA)
Michael Dybbs, PhD
Partner, Samsara BioCapital
Bilal Khan
Board Director, New World Medical
Kirk Nielsen
Board Director, Vensana Capital
Elizabeth O’Farrell
Board Director
Geoff Pardo
Board Director, Gilde Healthcare US
Zach Scheiner, PhD
Board Director, RA Capital
Medical Advisory Board
With guidance from top ophthalmic specialists, we’re ensuring every SpyGlass innovation meets the highest standards of safety, precision, and patient care.
Robert Cionni, MD
The Eye Institute of Utah
Tom Frinzi
Health Care Advisor
Sam Garg, MD
Gavin Herbert Eye Institute/UC Irvine
Preeya Gupta, MD
Triangle Eye Consultants
Cathleen McCabe, MD
Eye Health America
Jai G. Parekh, MD, MBA, FAAO
Senior Healthcare Executive
Nathan Radcliffe, MD
New York Eye Surgery Center
Darrell White, MD
SkyVision Centers